Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK

<p><strong>Background</strong> X-linked hypophosphataemia (XLH) is a rare genetic condition passed on through the X chromosome which causes multiple symptoms including weakened teeth, bones, and muscles. Due to the rarity of the condition, little is known about the health outcomes...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Cole, S, Sanchez-Santos, MT, Kolovos, S, Javaid, MK, Pinedo-Villanueva, R
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	BioMed Central 2023

Eitemau Tebyg

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK
gan: Sophie Cole, et al.
Cyhoeddwyd: (2023-02-01)

Subgroups of adults with X-linked hypophosphataemia: cluster analysis of patient-reported outcome measures of participants in a UK rare diseases cohort
gan: Cole, S, et al.
Cyhoeddwyd: (2021)

Patient-reported outcomes of X-linked hypophosphataemia registry participants in the UK
gan: Cole, S, et al.
Cyhoeddwyd: (2021)

A longitudinal study of patient-reported outcomes of RUDY registry participants with X-linked hypophosphataemia in the UK
gan: Cole, S, et al.
Cyhoeddwyd: (2021)

A cross-sectional study of patient-reported outcomes of individuals with X-linked hypophosphataemia within the UK
gan: Cole, S, et al.
Cyhoeddwyd: (2021)

Cluster analysis of patient-reported outcome measures of adults with X-linked hypophosphataemia
gan: Cole, S, et al.
Cyhoeddwyd: (2022)

Valuation of lost productivity of adults with X-linked Hypophosphataemia and Osteogenesis imperfecta
gan: Cole, S, et al.
Cyhoeddwyd: (2023)

Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: A UK parallel cohort study using CPRD
gan: Hawley, S, et al.
Cyhoeddwyd: (2020)

X-linked hypophosphataemia: prevalence and mortality rate within the United Kingdom Clinical Practice Research Datalink
gan: Hawley, S, et al.
Cyhoeddwyd: (2019)

X-linked hypophosphataemia: burden of disease using United Kingdom primary care data
gan: Javaid, M, et al.
Cyhoeddwyd: (2018)

Change in patient-reported outcomes of XLH registry participants in the UK: a longitudinal study
gan: Cole, S, et al.
Cyhoeddwyd: (2021)

Prevalence and mortality of individuals with X-linked hypophosphataemia: a United Kingdom real world data analysis
gan: Hawley, S, et al.
Cyhoeddwyd: (2019)

Quality of life in adults with X-linked hypophosphataemia (XLH): Preservation of emotional well-being despite significant limitations in physical domains
gan: Pinedo-Villanueva, R, et al.
Cyhoeddwyd: (2017)

Left Ventricular Hypertrophy in Patients with X-Linked Hypophosphataemia
gan: Ana Castellano-Martinez, et al.
Cyhoeddwyd: (2022-09-01)

Valuation of lost productivity for individuals diagnosed with Osteogenesis imperfecta: follow-up findings from the Rudy Cohort Study in the UK
gan: Cole, S, et al.
Cyhoeddwyd: (2022)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
gan: Karine Briot, et al.
Cyhoeddwyd: (2023-02-01)

Mutations of the PEX regulatory and C-terminal regions cause X-linked hypophosphataemia.
gan: Dixon, P, et al.
Cyhoeddwyd: (1997)

XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
gan: Lothar Seefried, et al.
Cyhoeddwyd: (2023-10-01)

Hospital admissions of patients with osteogenesis imperfecta in the English NHS
gan: Kolovos, S, et al.
Cyhoeddwyd: (2021)

Prevalence of cardiovascular disease events and determinants in patients with x-linked hypophosphatemia
gan: Maronga, C, et al.
Cyhoeddwyd: (2023)

Prevalence and risk factors of hypertension among patients with X-linked hypophosphatemia
gan: Maronga, C, et al.
Cyhoeddwyd: (2023)

Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study
gan: Takuo Kubota, et al.
Cyhoeddwyd: (2020-06-01)

Description of hospital use by patients with osteogenesis imperfecta in the English NHS
gan: Kolovos, S, et al.
Cyhoeddwyd: (2020)

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study
gan: Raja Padidela, et al.
Cyhoeddwyd: (2020-06-01)

Rare genetic diseases of the bone tissue: the case of a family with osteogenesis imperfecta and X-linked hypophosphataemia
gan: Irina Yu. Popova, et al.
Cyhoeddwyd: (2018-04-01)

Hypophosphataemia masquerading as ankylosing spondylitis
gan: Wordsworth, B, et al.
Cyhoeddwyd: (2008)

Identification of a Novel Missense Mutation of the PHEX Gene in a Large Chinese Family with X-Linked Hypophosphataemia
gan: Yanting Yang, et al.
Cyhoeddwyd: (2022-02-01)

A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH).
gan: Vrinda Saraff, et al.
Cyhoeddwyd: (2024-01-01)

Hypophosphataemia: An under-recognized cause of spondyloarthropathy
gan: Wordsworth, P, et al.
Cyhoeddwyd: (2008)

Improvements with burosumab treatment in an early access programme for adults with X-linked hypophosphataemia: A case series of three patients
gan: Julia Day, et al.
Cyhoeddwyd: (2024-12-01)

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description
gan: Maria Luisa Brandi, et al.
Cyhoeddwyd: (2022-09-01)

A literature review of the healthcare resource use and productivity burden of X-linked hypophosphatemia
gan: Pinedo Villanueva, R, et al.
Cyhoeddwyd: (2023)

Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.
gan: Wainwright, E, et al.
Cyhoeddwyd: (2013)

Early hypophosphataemia in at risk newborns. Frequency and magnitude
gan: Gerardo Bustos Lozano, et al.
Cyhoeddwyd: (2018-04-01)

Isolated hypophosphataemia as an early marker of primary hyperparathyroidism
gan: John Alexander, et al.
Cyhoeddwyd: (2021-06-01)

Disease burden and health-related quality of life among children with X-linked hypophosphataemia in China: a national cross-sectional survey
gan: Li Liu, et al.
Cyhoeddwyd: (2025-03-01)

Valuation of lost productivity for people with osteogenesis imperfecta: preliminary results from the RUDY cohort
gan: Cole, SE, et al.
Cyhoeddwyd: (2022)

Severe asymptomatic hypophosphataemia in a child with T-acute lymphoblastic leukaemia
gan: Zakaria, N.H., et al.
Cyhoeddwyd: (2017)

An uncommon cause for severe hypophosphataemia after transsphenoidal pituitary surgery
gan: Ramamani Mariappan, et al.
Cyhoeddwyd: (2014-05-01)

Acute onset quadriparesis following oesophagectomy due to isolated hypophosphataemia
gan: Vibhavari M Naik, et al.
Cyhoeddwyd: (2019-01-01)